Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Rapamycin Extends Life Span in ApcMin/+ Colon Cancer FAP Model

Clinical Colorectal Cancer(2020)10.1016/j.clcc.2020.08.006Source: DataRank Database

Rapamycin Extends Life Span in ApcMin/+ Colon Cancer FAP Model is a research paper published in Clinical Colorectal Cancer (2020). On theSindex it has a DataRank of 0. It has been cited 40 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access40 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)Impact (FWCI 2.53)OA: hybridTopics (58)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Sherry G. Dodds ORCID,Gene B. Hubbard,Martin A. Javors ORCID,Randy Strong ORCID,Paul Hasty ORCID

Live enrichment

PubMed:33132009 PMC:PMC7956131 OpenAlex:https://openalex.org/W3087640284

National Institutes of Health

Grant: R01- CA193835

National Institutes of Health

Grant: U01AG022307-16

National Institutes of Health

Grant: P01AG017242-17A1

National Institutes of Health

Grant: R01 CA188032-01

NIA NIH HHS

Grant: P30 AG013319

BLRD VA

Grant: I01 BX001641

NIA NIH HHS

Grant: P01 AG017242

NCI NIH HHS

Grant: R01 CA193835

NCI NIH HHS

Grant: R01 CA188032

NIA NIH HHS

Grant: U01 AG022307

National Institutes of Health

Grant: 5R01CA188032-03

How does TREX2 maintain and alter chromosomes?

National Institutes of Health

Grant: 1R01CA193835-01A1

Delaying intestinal cancer

National Institutes of Health

Grant: 5P01AG017242-27

DNA Repair, Mutations and Cellular Aging

National Institutes of Health

Grant: 5U01AG022307-17

Center for Testing Potential Anti-Aging Interventions

National Institutes of Health

FWCI

2.53

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

hybridLicense: cc-by-nc-nd

journalhttp://www.clinical-colorectal-cancer.com/article/S1533002820301237/pdf

publisherhttp://www.clinical-colorectal-cancer.com/article/S1533002820301237/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1533002820301237?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1533002820301237?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.clcc.2020.08.006

Fields of Study

PI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase SignalingCancer Cells and Metastasis0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Mechanistic Target of Rapamycin Complex 1AnimalsColonColonic NeoplasmsDisease Models, AnimalFemaleHeterozygoteHumansIntestinal MucosaMaleMice, TransgenicTime FactorsSurvival AnalysisSirolimusAdenomatous Polyposis Coli ProteinMiceCarcinogenesis

Keywords

AzoxymethanemTORC1Colorectal cancerMedicineSirolimusFamilial adenomatous polyposisCryptCancer researchPI3K/AKT/mTOR pathwayInternal medicineP70-S6 Kinase 1CancerGastroenterologyBiologySignal transductionAgingEef2kRps6Crypt Stem CellsMaleHeterozygoteTime FactorsCarcinogenesisColonAdenomatous Polyposis Coli ProteinMice, TransgenicMechanistic Target of Rapamycin Complex 1Survival AnalysisDisease Models, AnimalMiceColonic NeoplasmsAnimalsHumansFemaleIntestinal Mucosa

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being